| 664298 |
ONCOLOGY LETTERS |
Altered glycolysis results in drug‑resistant in clinical tumor therapy (Review) |
2021-03-11 |
10.3892/ol.2021.12630 |
Peng Jinghui, Cui Yangyang, Xu Shipeng, Wu Xiaowei, Huang Yue, Zhou Wenbin, Wang Shui, Fu Ziyi, Xie Hui |
| 664297 |
ONCOLOGY LETTERS |
LINC00052 promotes breast cancer cell progression and metastasis by sponging miR‑145‑5p to modulate TGFBR2 expression |
2021-03-11 |
10.3892/ol.2021.12629 |
Dong Menglu, Xu Tao, Li Hanning, Li Xingrui |
| 664296 |
BIOMEDICINES |
The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE Study |
2021-03-11 |
10.3390/biomedicines9030286 |
Colombo Gualtiero, Bianconi Vanessa, Bonomi Alice, Simonelli Sara, Amato Mauro, Frigerio Beatrice, Ravani Alessio, Vitali Cecilia, Sansaro Daniela, Coggi Daniela, Mannarino Massimo, Savonen Kai, Kurl Sudhir, Gigante Bruna, Smit Andries, Giral Philippe, Tremoli Elena, Calabresi Laura, Veglia Fabrizio, Pirro Matteo, Baldassarre Damiano, on behalf of the IMPROVE Study Group |
| 664295 |
BIOMEDICINES |
Cerebroprotective Effects of 2-Ethyl-6-methyl-3-hydroxypyridine-2,6-dichlorophenyl(amino)phenylethanoic Acid in the Treatment of Purulent Meningitis |
2021-03-11 |
10.3390/biomedicines9030285 |
Agarkova Alina, Pokrovskii Mikhail, Kolesnichenko Pavel, Gureev Vladimir, Gudyrev Oleg, Peresypkina Anna, Soldatov Vladislav, Nesterov Arkadii, Denisyuk Tatyana, Korokin Mikhail |
| 664294 |
THE ONCOLOGIST |
Effects of ado‐trastuzumab emtansine and fam‐trastuzumab deruxtecan on metastatic breast cancer harboring HER2 amplification and the L755S mutation |
2021-03-11 |
10.1002/onco.13715 |
Mukohara Toru, Hosono Ako, Mimaki Sachiyo, Nakayama Akiko, Kusuhara Shota, Funasaka Chikako, Nakao Takehiro, Fukasawa Yoko, Kondoh Chihiro, Harano Kenichi, Naito Yoichi, Matsubara Nobuaki, Tsuchihara Katsuya, Kuwata Takeshi |
| 664293 |
THE ONCOLOGIST |
Measuring Ovarian Escape in Premenopausal Estrogen Receptor Positive Breast Cancer Patients on Ovarian Suppression Therapy |
2021-03-11 |
10.1002/onco.13722 |
Burns Ethan, Koca Emre, Xu Jiaqiong, McLean Edward, Lee Rosetta, Patel Tejal, Chang Jenny, Niravath Polly |
| 664292 |
THE ONCOLOGIST |
A review of immunotherapy for stage 3 and metastatic NSCLC & the rationale for the ECOG‐ACRIN EA5181 study |
2021-03-11 |
10.1002/onco.13725 |
Varlotto John M, Sun Zhuoxin, Ky Bonnie, Upshaw Jenica, Katz Sharyn I, Fitzgerald Thomas J, Wakelee Heather, Diehn Maximilian, Mankoff David A, Lovly Christine, Belani Chandra, Oettel Kurt, Masters Gregory, Ramalingam Suresh, Pennell Nathan A |
| 664291 |
PEDIATRIC BLOOD & CANCER |
Presentation acuity, induction mortality, and resource utilization in infants with acute leukemia |
2021-03-11 |
10.1002/pbc.28940 |
Ibrahimova Azada, Winestone Lena E., Miller Tamara P., Kettler Kyle, Seif Alix E., Huang Yuan‐Shung, Elgarten Caitlin W., Myers Regina M., Fisher Brian T., Aplenc Richard, Getz Kelly D. |
| 664290 |
PEDIATRIC BLOOD & CANCER |
Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors |
2021-03-11 |
10.1002/pbc.28970 |
Puthenpura Vidya, Canavan Maureen E., Poynter Jenny N., Roth Michael, Pashankar Farzana D., Jones Beth A., Marks Asher M. |
| 664289 |
ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE |
Effects of maternal exposure to arsenic on social behavior and related gene expression in F2 male mice |
2021-03-11 |
10.1186/s12199-021-00956-y |
Htway Soe-Minn, Suzuki Takehiro, Kyaw Sanda, Nohara Keiko, Win-Shwe Tin-Tin |
